focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Regulatory News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.75
Bid: 4.00
Ask: 5.50
Change: -0.25 (-5.00%)
Spread: 1.50 (37.50%)
Open: 5.00
High: 5.00
Low: 4.75
Prev. Close: 5.00
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further investment in Conjunct

20 Dec 2011 07:00

RNS Number : 2706U
Braveheart Investment Group plc
20 December 2011
 



20 December 2011

 

 

 

Braveheart Investment Group plc

 

Further investment in Conjunct Limited

 

 

Braveheart Investment Group (AIM: BRH) ('Braveheart' or the 'Group'), the AIM-listed specialist in growth capital investments for business angels, high net worth individuals and family offices, announces that it has led a third round of funding for its portfolio company Conjunct Limited. Investors in the c£340,000 round included the Group, Braveheart clients and Scottish Investment Bank's Scottish Co-investment Fund.

 

With the growth of the internet and an unprecedented demand for faster data transfer, fibre optic cabling is becoming mainstream, replacing traditional copper cables. To achieve faster connectivity within the fibre optic cable networks and support higher data rates, Conjunct has developed a highly innovative transceiver module, Fibre-Lyte. It is a novel packaging solution which can be applied to both datacoms and telecoms markets and has the potential to support data rates up to 300Gbps.

 

Conjunct, which is based in Livingston, central Scotland, has engaged with global organisations to integrate Fibre-Lyte into their product lines. The new money will be used to support Conjunct's production engineering activities for Fibre-Lyte manufacture and to complete development of a new Fibre-Lyte variant.

 

Geoffrey Thomson, Chief Executive of Braveheart, said: "Conjunct is now well placed to take advantage of the high demand for innovative optoelectronic solutions such as Fibre-Lyte and Conjunct is now in advanced discussions with the leading market players in optical systems."

 

Ken Allstaff, CEO of Conjunct, commented: "We are keen to move to the next stage of the Company's growth and are delighted to have again secured backing from Braveheart to allow us to offer Fibre-Lyte at costs and quantities which will enable continued market traction."

 

For further information please visit www.braveheartinvestmentgroup.co.uk and www.conjunct.co.uk or contact:

 

Braveheart Investment Group

Conjunct Limited

Geoffrey Thomson, Chief Executive

Ken Allstaff, Chief Executive

Tel: 01738 587555

Tel: 01506 465700

gthomson@braveheart-ventures.co.uk

ken.allstaff@conjunct.co.uk

 

 

Seymour Pierce Limited

Allerton Communications (for Braveheart)

Freddy Crossley (Nominated Adviser)

Peter Curtain

Paul Jewell / David Banks (Corporate broking)

Tel: 020 3137 2500

Tel: 020 7107 8000

peter.curtain@allertoncomms.co.uk

 

Notes to Editors

Braveheart Investment Group makes and manages investments in young, emerging British companies, specialising in building tax efficient portfolios for business angels, high net worth individuals and family offices. Braveheart was founded in 1997 by a small group of investors to encourage and syndicate investments in privately held companies that offered opportunities for significant growth. Fourteen years on, Braveheart is a public company with a demonstrable track record in technology investing, an established client base and various funds under management. The Group has offices in Perth, London, Yorkshire and Jersey with franchise operations in Dubai and Manchester.

 

Investments are made in unlisted companies where there is potential for significant growth through successful commercialisation of IP. Through close relationships with leading universities and innovation centres, Braveheart has access to a wide variety of emerging commercial opportunities at early stages. There are currently some 45 companies in Braveheart's diverse portfolio (includes all companies where the Group has a financial interest) and it has completed more than 90 deals.

 

Following the 2010 acquisition of Envestors Limited, the London based specialist corporate finance advisory business, Braveheart offers a unique and comprehensive suite of tax efficient products to high net worth investors.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCTLBFTMBMBBAB
Date   Source Headline
19th Jul 201812:15 pmRNSResult of AGM and GM
16th Jul 20187:00 amRNSUpdate on fund management business
12th Jul 20187:00 amRNSProposed funding round by Paraytec Limited
10th Jul 201810:44 amRNSHolding(s) in Company
25th Jun 20187:00 amRNSFurther re. Notice of Annual General Meeting
21st Jun 20185:16 pmRNSConfirmation of Posting
20th Jun 201810:30 amRNSAppointment of Joint Broker
18th Jun 20187:02 amRNSNotice of General Meeting
18th Jun 20187:00 amRNSFinal Results
26th Apr 20187:00 amRNSTrading Update
9th Apr 20185:11 pmRNSThird party investment into Gyrometric Systems Ltd
16th Jan 20184:24 pmRNSChange of Registered Office
19th Oct 20177:00 amRNSHalf-year Report
13th Sep 20177:00 amRNSUpdate re. Portfolio investment
1st Sep 20177:00 amRNSRetirement of Director and Total Voting Rights
8th Aug 20177:00 amRNSIssue of Equity
20th Jul 201711:19 amRNSResult of AGM
20th Jul 20177:00 amRNSAGM Statement
21st Jun 20177:00 amRNSFinal Results for the year ended 31 March 2017
7th Jun 20174:08 pmRNSDirectorate Change
20th Apr 20177:00 amRNSTrading Update
9th Jan 20177:00 amRNSStrategic Investment and Trading Update
12th Oct 20167:00 amRNSHalf-year Report
16th Sep 201611:18 amRNSDisposal of interest in Investee Company
2nd Aug 201612:08 pmRNSConditional disposal of interest-Investee Company
29th Jul 201611:13 amRNSStmnt re Share Price Movement
26th Jul 20169:32 amRNSHolding(s) in Company
19th Jul 201611:46 amRNSResult of AGM
19th Jul 20167:00 amRNSAGM Statement
13th Jul 20163:26 pmRNSDirectors' Dealings
8th Jul 20163:07 pmRNSInvestment in Kirkstall Limited
4th Jul 20167:00 amRNSInvestment in Paraytec Limited
23rd Jun 20168:45 amRNSAnnual Results
3rd Mar 20167:00 amRNSChange of Nomad & Broker and Directorate Changes
15th Jan 20169:36 amRNSDirectors' Dealings
8th Jan 201612:36 pmRNSDisposal of interest in WhiteRock Capital Partners
15th Dec 20152:33 pmRNSCompletion of sale of interest in Biopta
27th Nov 20157:00 amRNSDisposal of interest in Investee Company
2nd Nov 20152:35 pmRNSHalf Yearly Report & Disposal
24th Sep 201512:15 pmRNSResult of AGM and Directorate Change
3rd Sep 20157:00 amRNSDirector/PDMR Shareholding
2nd Sep 201512:30 pmRNSPosting of Results and Notice of AGM
24th Aug 20157:00 amRNSPreliminary Results and Board Changes
26th Jun 20152:20 pmRNSChange of address and registered office
6th May 20157:01 amRNSCompletion of restructuring and Directorate change
30th Apr 201511:21 amRNSBraveheart enters into partnership with Seedrs
30th Apr 20157:00 amRNSTermination of partnership
20th Apr 20157:00 amRNSDirectorate Change
23rd Dec 20147:00 amRNSRealisation of Investment
15th Dec 20147:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.